BIODELIVERY SCIENCES INT INC has a total of 141 patent applications. It decreased the IP activity by 70.0%. Its first patent ever was published in 2003. It filed its patents most often in United States, Australia and Canada. Its main competitors in its focus markets pharmaceuticals, medical technology and measurement are TESORX PHARMA LLC, PHOENIX U S A INC LAB and ALIATROS MEDICAL AS.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 43 | |
#2 | Australia | 17 | |
#3 | Canada | 8 | |
#4 | China | 8 | |
#5 | EPO (European Patent Office) | 7 | |
#6 | Brazil | 6 | |
#7 | Japan | 6 | |
#8 | Republic of Korea | 6 | |
#9 | WIPO (World Intellectual Property Organization) | 6 | |
#10 | Mexico | 5 | |
#11 | Singapore | 5 | |
#12 | Israel | 4 | |
#13 | New Zealand | 4 | |
#14 | Hong Kong | 3 | |
#15 | Norway | 3 | |
#16 | EAPO (Eurasian Patent Organization) | 2 | |
#17 | Ukraine | 2 | |
#18 | Hungary | 1 | |
#19 | India | 1 | |
#20 | Serbia | 1 | |
#21 | Russian Federation | 1 | |
#22 | Slovenia | 1 | |
#23 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Measurement | |
#4 | Foods and drinks | |
#5 | Machine tools | |
#6 | Organic fine chemistry | |
#7 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Dentistry | |
#4 | Syringes | |
#5 | Perforating | |
#6 | Analysing materials | |
#7 | Sugars | |
#8 | Foods | |
#9 | Food shaping | |
#10 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Finn Andrew | 112 |
#2 | Vasisht Niraj | 108 |
#3 | Andrew Finn | 12 |
#4 | Niraj Vasisht | 11 |
#5 | Webster Lynn R | 7 |
#6 | Kirby Todd | 7 |
#7 | Mannino Raphael J | 5 |
#8 | Schupp Jr Kenneth E | 3 |
#9 | Gould-Fogerite Susan | 3 |
#10 | Delmarre David | 2 |
Publication | Filing date | Title |
---|---|---|
WO2017147285A1 | Sustained release buprenorphine microspheres (srbm) and methods of use thereof | |
WO2017044745A1 | Methods of safely transitioning a subject to buprenorphine | |
WO2016086095A1 | Patches, methods for forming and testing pharmaceutical agent delivery patches | |
AU2015203167A1 | Multidirectional mucosal delivery devices and methods of use | |
CN104125828A | Transmucosal drug delivery devices for use in chronic pain relief | |
NZ724912A | Transmucosal drug delivery devices for use in chronic pain relief | |
US2014178440A1 | Transmucosal drug delivery devices for use in chronic pain relief | |
SG11201401446RA | Abuse-resistant mucoadhesive devices for delivery of buprenorphine | |
AU2011205222A1 | Transmucosal delivery devices with enhanced uptake | |
AU2011204898A1 | Nucleotide-cochleate compositions and methods of use | |
AU2009271271A1 | Multidirectional mucosal delivery devices and methods of use | |
KR20090033903A | Transmucosal delivery devices with enhanced uptake | |
UA96455C2 | Transmucosal delivery devices with enhanced uptake | |
BRPI0619806A2 | abuse resistant transmucosal drug delivery device |